We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ACHV market cap is 101.17M. The company's latest EPS is USD -1.4086 and P/E is -3.39.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.58M | -7.71M | -6.57M | -4.39M | -5.98M |
| Net Income | -8.99M | -8.24M | -7.11M | -5.48M | -6.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.53M | -14.75M | -33.09M | -40.8M | -27.25M |
| Net Income | -16.4M | -14.73M | -33.15M | -42.35M | -29.82M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.8M | 28.92M | 24.34M | 19.37M | 70.03M |
| Total Liabilities | 20.36M | 19.22M | 20.3M | 20.82M | 20.57M |
| Total Equity | 443k | 9.7M | 4.04M | -1.45M | 49.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.08M | 40.3M | 47.52M | 29.97M | 19.37M |
| Total Liabilities | 3.03M | 3.01M | 19.47M | 21.67M | 20.82M |
| Total Equity | 18.05M | 37.29M | 28.04M | 8.3M | -1.45M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.3M | -14.98M | -20.12M | -24.48M | -5.29M |
| Investing | N/A | N/A | -15k | -21k | N/A |
| Financing | 47k | 15.28M | 15.28M | 15.28M | 56.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.22M | -13.47M | -29.44M | -37.55M | -24.48M |
| Investing | 5.04M | -17k | N/A | N/A | -21k |
| Financing | 17.33M | 32.68M | 36.61M | 19.3M | 15.28M |
| Market Cap | 101.17M |
| Price to Earnings Ratio | -3.39 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.51 |
| Price to Book Ratio | -69.87 |
| Dividend Yield | - |
| Shares Outstanding | 21.17M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.85 (59.62%) |
| Company Name | Achieve Life Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.achievelifesciences.com |
| Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
